David Young - Jul 8, 2021 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ David Young by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Jul 8, 2021
Transactions value $
$0
Form type
4
Date filed
7/9/2021, 04:33 PM
Previous filing
Jun 23, 2021
Next filing
Aug 9, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Units Award $0 +8.57K $0.00 8.57K Jul 8, 2021 Common Stock 8.57K $0.00 Direct F1
transaction PCSA Restricted Stock Units Award $0 +12.9K $0.00 12.9K Jul 8, 2021 Common Stock 12.9K $0.00 Direct F2
transaction PCSA Restricted Stock Units Award $0 +1.91K +23.46% $0.00 10K Jul 8, 2021 Common Stock 10K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units vest in two equal installments beginning July 1, 2022.
F2 The Restricted Stock Units vest upon achievement of certain performance goals.
F3 Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock upon the earliest of: termination of employment; the third anniversary of the award date; a change of control; or the reporting person's death.